HCQ AND HIV the anti-malaria drug hydroxychloroquine, chosen to contain the immune stimulant effects of vorinostat and prevent runaway HIV infection; and the entry inhibitor maraviroc, chosen because it has the potential to stop HIV spreading to new cells once the reservoir cells are woken up.